MARA Holdings
MARA
Microsoft
MSFT
Apple
AAPL
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
DXCM DexCom
- 80.550
- +0.080+0.10%
Trading Dec 12 10:44 ET
31.46BMarket Cap48.82P/E (TTM)
80.740High79.808Low448.46KVolume80.180Open80.470Pre Close36.02MTurnover0.12%Turnover Ratio61.96P/E (Static)390.60MShares142.00052wk High15.90P/B31.21BFloat Cap62.34052wk Low--Dividend TTM387.46MShs Float164.863Historical High--Div YieldTTM1.16%Amplitude0.340Historical Low80.329Avg Price1Lot Size
About DexCom Company
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Company Profile
SymbolDXCM
Company NameDexCom
Listing DateApr 14, 2005
Issue Price12.00
Founded1999
MarketNASDAQ
Employees9600
Fiscal Year Ends12-31
Address6340 Sequence Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-200-0200
Websitehttp://www.dexcom.com
Company Executives
- Name
- Position
- Salary
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 15.71M
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 4.34M
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 4.25M
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 6.53M
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 4.94M
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Richard A. Collins
- Independent Director
- 345.90K
- Mark G. Foletta
- Lead Independent Director
- 393.51K
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 346.49K
- Karen M. Dahut
- Independent Director
- 345.90K
- Steven R. Altman
- Independent Director
- 343.40K
- Rimma Driscoll
- Independent Director
- 404.72K
- Bridgette P. Heller
- Independent Director
- 346.49K
- Nicholas Augustinos
- Independent Director
- 362.21K
- Kyle Malady
- Independent Director
- 343.40K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
